VREX
Varex Imaging Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow -10.1% ·
net new positions -7.7%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 16.05K | $296,388 | n/a | −1 |
| Q2 2026 | 73 | +1 | 23.53M | $245.80M | +4 | −3 |
| Q1 2026 | 74 | -2 | 23.68M | $251.27M | +5 | −7 |
| Q4 2025 | 76 | +1 | 25.15M | $293.07M | +1 | n/a |
| Q3 2025 | 16 | 0 | 13.89M | $172.28M | +1 | −1 |
| Q2 2025 | 13 | -1 | 12.33M | $106.93M | +1 | −2 |
| Q1 2025 | 11 | -1 | 6.63M | $76.87M | n/a | −1 |
| Q4 2024 | 12 | 0 | 6.74M | $98.34M | +1 | −1 |
| Q3 2024 | 11 | +1 | 5.38M | $64.17M | +3 | −2 |
| Q2 2024 | 10 | n/a | 2.74M | $40.40M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 3.94M | n/a | $34.16M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 2 | The Vanguard Group ✦ (passive) | 2.86M | n/a | $24.83M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 3 | State Street Global Advisors ✦ (passive) | 1.06M | -39.8% | $9.19M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 989.06K | +2.7% | $8.58M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | D. E. Shaw & Co. ✦ | 937.69K | +119.3% | $8.13M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 572.00K | +56.5% | $4.96M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 471.62K | +50.3% | $4.09M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 8 | Millennium Management ✦ | 415.52K | -8.9% | $3.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 305.20K | -1.1% | $2.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 282.34K | n/a | $2.45M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Two Sigma Investments ✦ | 263.06K | +18.1% | $2.28M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 213.01K | New | $1.85M | 0.0% | New | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 20.96K | +23.8% | $182,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $1.85M | 0.0% |
Exited
| Wellington Management | $17.93M | was 0.0% |
| Marshall Wace | $2.87M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 176 holders, 41.13M shares, $401.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 8.12K sh · $150,076
Officer · 130.00K sh · $2.40M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology